Israel's InMode Q3 revenue slightly beats estimates on Asia growth

By Reuters News


Overview

  • Israel medical device maker's Q3 revenue was nearly flat yr/yr, slightly beating analyst expectations

  • Q3 adjusted EPS met analyst expectations

  • Consumables and service revenue fell 3% yr/yr; margins narrowed on higher expenses


Outlook

  • InMode reaffirms 2026 revenue guidance of $365 mln to $375 mln

  • Company expects 2026 non-GAAP EPS between $1.29 and $1.34

  • InMode anticipates 2026 non-GAAP gross margin of 74% to 76%


Result Drivers

  • ASIA GROWTH - Co said revenues in Asia reached a quarterly record due to sustained demand across key markets

  • HIGHER EXPENSES - Co attributed lower operating margins to restructuring of North American sales team, increased sales and marketing investments, and higher professional services costs

  • TARIFF REFUND - Gross margin benefited from a non-recurring U.S. tariff refund, which increased gross margin by about one percentage point


Company press release:


Key Details

Metric

Beat/Miss

Actual

Consensus Estimate

Q3 Revenue

Slight Beat*

$92.14 mln

$91.60 mln (5 Analysts)

Q3 EPS

Meet

$0.32

$0.32 (5 Analysts)

Q3 Net Income
(GAAP)

$18.86 mln

Q3 Gross Margin

78.00%

Q3 Income from Operations

Beat

$17.51 mln

$17.02 mln (5 Analysts)

Q3 Pretax Profit

Beat

$22.22 mln

$21.47 mln (3 Analysts)

Q3 Operating Expenses

$54.29 mln

*Applies to a deviation of less than 1%; not applicable for per-share numbers.


Reuters Recommended Reads

  • Nov 10 - Switzerland's Alcon Q3 sales slightly miss estimates despite surgical equipment launches, vision care growth

  • Nov 10 - LENSAR Q3 revenue slightly misses estimates on slower surgical scheduling

  • Nov 10 - Surgical robotics firm Stereotaxis' Q3 revenue rises, but misses estimates


For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.


(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

Capital.com is an execution-only brokerage platform and the content provided on the Capital.com website is intended for informational purposes only and should not be regarded as an offer to sell or a solicitation of an offer to buy the products or securities to which it applies. No representation or warranty is given as to the accuracy or completeness of the information provided.
The information provided does not constitute investment advice nor take into account the individual financial circumstances or objectives of any investor. Any information that may be provided relating to past performance is not a reliable indicator of future results or performance.
To the extent permitted by law, in no event shall Capital.com (or any affiliate or employee) have any liability for any loss arising from the use of the information provided. Any person acting on the information does so entirely at their own risk.
 

Cryptocurrency-related content is intended solely as news and market commentary. Crypto Derivatives are not available to Retail clients registered with Capital Com (UK) Ltd.